Generics Industry News Search
 |
|
|
|
|
|
|
December 2011 News Archive |
|
|
| |
|
Teva Pharmaceutical Industries Ltd., the world's biggest maker of generic drugs, lost an appeals court bid to revive a patent it claimed AstraZeneca Plc's cholesterol drug Crestor was infringing...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Ranbaxy Pharmaceuticals Inc., a wholly owned subsidiary of Ranbaxy Laboratories Ltd., today announced that it has received final approval from the U.S. Food and Drug Administration to manufacture and market Atorvastatin and has launched the product in the U.S. market...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Amlodipine Besylate and Atorvastatin Calcium Tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan Inc. was sued by a unit of Warner Chilcott Plc for infringing a U.S. patent with plans to market low-cost copies of the oral contraceptive Generess FE...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis Group, the international generic pharmaceuticals company, has acquired 100% of the shares in PharmaPack International B.V. for an undisclosed amount...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan Inc. today announced that its business Mylan Institutional has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Tranexamic Acid Injection...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sanofi SA said in a letter sent to customers dated Nov. 30 that it has discontinued selling the Authorized Generic version of Lovenox...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The U.S. Supreme Court on Monday grappled with whether to allow generic drug makers to file certain legal counterclaims against brand-drug companies in an effort to get their cheaper copycat medicines on the market...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Ranbaxy has launched an authorised generic version of Caduet in the U.S. market, as part of an agreement with Pfizer...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Genmab announced today that Genentech and Biogen Idec have appealed the judgment in favor of GlaxoSmithKline in a patent infringement case involving Arzerra brought against GSK by Genentech and Biogen Idec...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Watson Pharmaceuticals, Inc. today announced that under a settlement with Teva Women's Health, Watson has launched Amethia Lo tablets, the generic equivalent of Teva Women's Health, Inc.'s LoSeasonique...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva Pharmaceutical Industries Ltd.'s Cephalon unit won an appeals court decision that prevents Watson Pharmaceuticals Inc. from selling a generic copy of the painkiller Fentora until 2019...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Ultram ER, Tramadol hydrochloride extended release tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
AstraZeneca has signed an agreement to acquire Guangdong BeiKang Pharmaceutical Company, a China-based generics manufacturing company...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan Inc. won an appeals court ruling in its bid to sell generic versions of Warner Chilcott Plc's antibiotic Doryx...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Warner Chilcott plc today announced that the U.S. Court of Appeals for the Federal Circuit vacated a preliminary injunction granted by the U.S. District Court for the District of New Jersey against Mylan Inc. and its affiliate Mylan Pharmaceuticals Inc. and remanded the matter to the District Court for further proceedings...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Lannett Company, Inc. today announced it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Triamterene with Hydrochlorothiazide Capsules...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Avaxia Biologics, a privately-held biotech company developing oral antibody drugs that act locally within the gastrointestinal tract, announced today that the company was awarded U.S. Patent 8,071,101, "Antibody Therapy for Treatment of Diseases Associated With Gluten Intolerance"...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Ranbaxy Laboratories has managed to capture close to 2.5 per cent of the generic Lipitor's market share in the US within the first few days of the launch...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Metoprolol Succinate Extended-release Tablets USP...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Valeant Pharmaceuticals International, Inc. today announced that it had made a proposal to the Board of Directors of ISTA Pharmaceuticals Inc. to acquire ISTA for $6.50 per share in cash. The proposed transaction has a total equity value of approximately $314 million on a fully diluted basis...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Agreement on the European Union's first region-wide patent system is unlikely this year because of the "contentious issue" of where to locate the court, the Polish presidency of the EU said...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Amgen and Watson Pharmaceuticals, Inc. announced today that they will collaborate to develop and commercialize, on a worldwide basis, several oncology antibody biosimilar medicines...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Repligen Corporation announced today that it has completed the acquisition of the business of Novozymes Biopharma Sweden AB, the Swedish unit of Novozymes Biopharma, a company focused on the manufacture and supply of growth factors used in mammalian cell culture and Protein A affinity ligands used in the production of monoclonal antibodies...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sandoz today announced the US Food and Drug Administration approval and US launch of voriconazole tablets, a generic equivalent of Vfend...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Zydus Cadila has acquired 100% stake in Biochem, one of the top 40 pharma companies in India. A privately-held company headquartered in Mumbai, Biochem is a well-integrated pharma player with a presence in the antibiotics, cardiovascular, anti-diabetic and oncological segments...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Baxter and Momenta today announced that they have entered into a global collaboration to develop and commercialise follow-on biologic products, also known as biosimilars...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Eprosartan Mesylate Tablets, 400 mg and 600 mg...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Levetiracetam Extended-release tablets, 500 mg and 750 mg...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Perrigo Company today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for Desloratadine tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva ships its generics version of GSK's Combivir for HIV in the U.S...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Lupin Ltd., announced today that its subsidiary, Lupin Pharmaceuticals Inc. (collectively, Lupin) has received final approval for its Fenofibrate tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
|
|
Contribute
If you would like to contribute or publish your
company press releases at GenericsWeb, please
email us.
|
Home
